Menopause practitioner perspective on the American Society of Bone and Mineral Research Task Force report on atypical femoral fracture

2013 ◽  
Vol 20 (10) ◽  
pp. 1092-1097 ◽  
Author(s):  
Bruce Ettinger ◽  
Cynthia A. Stuenkel ◽  
Peter F. Schnatz
Keyword(s):  
Femoral Fracture ◽  
Task Force ◽  
Atypical Femoral Fracture ◽  
Mineral Research ◽  
Task Force Report ◽  
Research Task ◽  
American Society

scholarly journals American Society for Bone and Mineral Research‐Orthopaedic Research Society Joint Task Force Report on Cell‐Based Therapies

2019 ◽  
Vol 35 (1) ◽  
pp. 3-17 ◽  
Author(s):  
Regis J O'Keefe ◽  
Rocky S Tuan ◽  
Nancy E Lane ◽  
Hani A Awad ◽  
Frank Barry ◽  
...  
Keyword(s):  
Task Force ◽  
Research Society ◽  
Mineral Research ◽  
Task Force Report ◽  
Orthopaedic Research ◽  
Joint Task ◽  
Joint Task Force ◽  
American Society

scholarly journals American Society for Bone and Mineral Research‐Orthopaedic Research Society Joint Task Force Report on Cell‐Based Therapies – Secondary Publication

2020 ◽  
Vol 38 (3) ◽  
pp. 485-502 ◽  
Author(s):  
Regis J. O'Keefe ◽  
Rocky S. Tuan ◽  
Nancy E. Lane ◽  
Hani A. Awad ◽  
Frank Barry ◽  
...  
Keyword(s):  
Task Force ◽  
Research Society ◽  
Mineral Research ◽  
Task Force Report ◽  
Orthopaedic Research ◽  
Joint Task ◽  
Joint Task Force ◽  
American Society

scholarly journals Bisphosphonates and Atypical Fractures of Femur

2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Tero Yli-Kyyny
Keyword(s):  
Task Force ◽  
Case Reports ◽  
Term Treatment ◽  
Mineral Research ◽  
Task Force Report ◽  
Treatment Of Osteoporosis ◽  
Atypical Fractures ◽  
Long Term Treatment ◽  
American Society

Bisphosphonates are the most widely prescribed medicines for the treatment of osteoporosis and have generally been regarded as well-tolerated and safe drugs. Since 2005, there have been numerous case reports about atypical fractures of the femur linked to long-term treatment of osteoporosis with bisphosphonates. Some attempts to characterize pathophysiology and epidemiology of these fractures have been published as well. However, as the American Society for Bone and Mineral Research (ASBMR) concluded in their task force report, the subject warrants further studies.

scholarly journals Korean Society for Bone and Mineral Research Task Force Report: Perspectives on Intermittent High-dose Vitamin D Supplementation

2017 ◽  
Vol 24 (3) ◽  
pp. 141 ◽  
Author(s):  
Han Seok Choi ◽  
Yong-Ki Min ◽  
Dong Won Byun ◽  
Myung Hoon Hahn ◽  
Kyoung Min Kim ◽  
...  
Keyword(s):  
Vitamin D ◽  
Task Force ◽  
Vitamin D Supplementation ◽  
High Dose ◽  
Mineral Research ◽  
Task Force Report ◽  
Korean Society ◽  
Research Task ◽  
High Dose Vitamin

scholarly journals Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy

2020 ◽  
Vol 15 (1) ◽  
Author(s):  
Dávid Dózsai ◽  
Tamás Ecseri ◽  
István Csonka ◽  
István Gárgyán ◽  
Péter Doró ◽  
...  
Keyword(s):  
Femoral Fracture ◽  
Case Reports ◽  
Femoral Stem ◽  
Femoral Fractures ◽  
Atypical Femoral Fracture ◽  
Periprosthetic Fractures ◽  
Periprosthetic Femoral Fracture ◽  
Mineral Research ◽  
Periprosthetic Femoral Fractures

Abstract Background Atypical femoral fracture is one of the many complications after the long-term use of bisphosphonates. The American Society for Bone and Mineral Research has officially excluded periprosthetic femoral fractures (PFFs) from the definition of atypical femoral fractures (AFFs). Several case reports found that PFFs can occur with characteristics similar to those of AFFs. The purpose of our study was to evaluate the proportion of atypical fractures among Vancouver type B1 fractures, and to determine the association between the long-term use of bisphosphonates and the occurrence of atypical periprosthetic femoral fractures (APFFs). Methods In this retrospective study, we reviewed 41 patients with Vancouver type B1 periprosthetic fractures between January 1, 2011 and December 31, 2018. We classified them into two groups, namely atypical and typical PFFs, based on the fracture morphology. We noted the proportion of atypical periprosthetic fractures among B1 fractures and identified risk factors. Results Among the 41 PFFs, 5 (13%) fractures were classified as atypical PFF based on the radiological characteristics. The longer duration of bisphosphonate use was probably the only independent risk factor that significantly increases the occurrence of APFF (p = 0.03, 0.08 (CI 0.008 – 0.16)). There were no significant differences in age, gender, body mass index, comorbidities, corticosteroid use, positioning of the femoral stem, the method of fixation (cemented or cementless) and time lapse from before the primary prosthesis implantation to the PFF in the development of atypical fracture type. Conclusions There seems to be a correlation between the long-term intake of bisphosphonates and the atypical periprosthetic fracture. Atypical femoral fracture can also occur in the periprosthetic form. Trial registration Study number: 22/2019-SZTE, http://www.klinikaikutatas.hu/hu/kutatasetika/jovahagyott-vizsgalatok-koezerdeku-adatai/category/25-jovahagyott-vizsgalatok-kozerdeku-adatai-rkeb-2019.html?download=985:22-2019.

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

2016 ◽  
Vol 31 (10) ◽  
pp. 1910-1910 ◽  
Author(s):  
Robert A Adler ◽  
Ghada El-Hajj Fuleihan ◽  
Douglas C Bauer ◽  
Pauline M Camacho ◽  
Bart L Clarke ◽  
...  
Keyword(s):  
Task Force ◽  
Bisphosphonate Treatment ◽  
Mineral Research ◽  
American Society

scholarly journals Pain, Quality of Life, and Safety Outcomes of Kyphoplasty for Vertebral Compression Fractures: Report of a Task Force of the American Society for Bone and Mineral Research

2017 ◽  
Vol 32 (9) ◽  
pp. 1935-1944 ◽  
Author(s):  
Alexander J Rodriguez ◽  
Howard A Fink ◽  
Lynn Mirigian ◽  
Nuria Guañabens ◽  
Richard Eastell ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Task Force ◽  
Vertebral Compression Fractures ◽  
Mineral Research ◽  
Compression Fractures ◽  
Safety Outcomes ◽  
American Society

Antiphospholipid Syndrome Clinical Research Task Force Report

Lupus ◽  
2011 ◽  
Vol 20 (2) ◽  
pp. 219-224 ◽  
Author(s):  
D Erkan ◽  
R Derksen ◽  
R Levy ◽  
S Machin ◽  
T Ortel ◽  
...  
Keyword(s):  
Clinical Research ◽  
Antiphospholipid Syndrome ◽  
Task Force ◽  
Task Force Report ◽  
Research Task
Sign in / Sign up

Export Citation Format

Share Document